Radiopharm Theranostics Health Care

$0.105 -0.010 (-8.70%)

High $0.12	Low $0.10	Trades 57	Turnover $206,557	Volume 1,951,148
30 June 2023 at 4:10pm

Register to track RAD and receive email alerts.

Market Cap (19-Sep) $44,934,040 (0th)	Close (30-Jun) $0.105 0 (0%)	Volume (30-Jun) 1,951,148	Shortsold (26-May) 2,077,074 (0.06%) (491st)
52w High $0.040	52w Low $0.017	P/E -	EPS -0.02

	Subject
	RAD RAD Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	1 (current) 2 3
	RAD RAD Ann: GenesisCare agreement extended to prostate cancer trial
	RAD RAD Ann: Dr Susann Brady-Kalnay added to Scientific Advisory Board
	RAD RAD Ann: Investor webinar - RAD adds brain tumor technology
	RAD RAD Ann: Supply agreement with Isotopia for Lutetium-177
	RAD RAD Ann: Investor Presentation
	RAD RAD Ann: RAD adds Brain Tumor Technology to Portfolio
	RAD RAD Ann: Initial Director's Interest Notice - LA
	RAD RAD Ann: RAD Appoints Dr Leila Alland as Non-Executive Director
	RAD RAD Ann: Industry leader Vittorio Puppo appointed COO
	RAD RAD Ann: Notification regarding unquoted securities - RAD
	RAD RAD Ann: Notice Under Section 708A
	RAD RAD Ann: Application for quotation of securities - RAD
	RAD RAD Ann: RAD presentation to Bioshares Biotech Summit
	RAD RAD Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RAD RAD Ann: Virtual investor conference presentation 2 May 2022
	RAD RAD Ann: Change of Director's Interest Notice - PH
	RAD RAD Ann: Change of Director's Interest Notice - IT
	RAD RAD Ann: Change of Director's Interest Notice - RC
	RAD RAD Ann: RAD Dual Action Antibody Investor Deck
	RAD RAD Ann: RAD Licenses UCLA Dual Action Antibody
	RAD RAD Ann: Change of Director's Interest Notice - HL
	RAD RAD Ann: Investor Presentation
	RAD RAD Ann: LOI with GenesisCare to start first trial in Australia
	RAD RAD Article: Biotech CEOs hit the streets amid sector sell-off
	RAD RAD Ann: Change of Director's Interest Notice - IT
	RAD RAD Ann: Half Yearly Report and Accounts
	RAD RAD Ann: Change in substantial holding NT
	RAD RAD Ann: Radiopharm and Terrapower supplementary announcement
	RAD RAD Ann: Initial Director's Interest Notice - HL
	RAD RAD Ann: Hester Larkin appointed as Non-Executive Director
	RAD RAD Ann: Director Appointment/Resignation
	RAD RAD Ann: Radiopharm and TerraPower sign Actinium 225 agreement
	RAD RAD Ann: Application for quotation of securities - RAD
	RAD RAD Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RAD RAD Ann: Proposed issue of securities - RAD
	RAD RAD Ann: RAD acquires IP Ownership of Radiopharmaceutical Nanobodies
	RAD RAD Ann: Change of Director's Interest Notice - RC
	RAD RAD Ann: RAD to present at Biotech Showcase
	RAD RAD Ann: Expansion of RAD management team
	RAD RAD Ann: Completion of Phase 1 imaging study in breast cancer
	RAD RAD Ann: Change of Director's Interest Notice - IT
	RAD RAD Ann: Change of Director's Interest Notice - PH
	RAD RAD Ann: Letter to shareholders
	RAD RAD Ann: Change of Director's Interest Notice - RC
	RAD RAD Ann: RAD Integrins technology featured in Cancers journal
	RAD RAD Ann: Dr Sara Hurvitz appointed to Scientific Advisory Board
	RAD RAD Ann: Change of Director's Interest Notice - IT
	RAD RAD Ann: Becoming a substantial holder - NT
	RAD RAD Ann: Change of Director's Interest Notice - PH

Register to track RAD and receive email alerts.

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.03	7,214,173	+0.00 (9.68%)
12-Sep	$0.03	19,871,583	+0.00 (6.90%)
11-Sep	$0.03	6,388,015	+0.00 (3.57%)
05-Sep	$0.03	2,120,535	0.00 (0.00%)
04-Sep	$0.03	4,651,023	+0.00 (5.66%)
03-Sep	$0.03	599,603	0.00 (5.36%)
29-Aug	$0.03	977,963	+0.00 (1.82%)
28-Aug	$0.03	1,712,009	+0.00 (1.85%)
22-Aug	$0.03	3,476,593	0.00 (10.00%)
21-Aug	$0.03	46,600,598	+0.00 (15.38%)
15-Aug	$0.03	2,085,119	+0.00 (6.12%)
14-Aug	$0.02	1,820,018	+0.00 (2.08%)
07-Aug	$0.02	1,331,698	+0.00 (4.35%)
31-Jul	$0.02	1,851,822	+0.00 (4.55%)
30-Jul	$0.02	3,321,092	0.00 (0.00%)
11 up, 2 down, and 2 flat days